Emicizumab and Insulin glulisine Subcutaneous
Determining the interaction of Emicizumab and Insulin glulisine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: n.a.
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-Insulin human inhaled Inhalation
- Emicizumab-Insulin human regular Injection
- Emicizumab-Insulin inhalation
- Emicizumab-Insulin isophane
- Emicizumab-Insulin isophane and insulin regular
- Emicizumab-Insulin lispro
- Insulin glulisine Subcutaneous-Emicizumab-kxwh
- Insulin glulisine Subcutaneous-Emicizumab-kxwh Subcutaneous
- Insulin glulisine Subcutaneous-Emla
- Insulin glulisine Subcutaneous-Emla Topical
- Insulin glulisine Subcutaneous-Emo-Cort Scalp Solution Topical application
- Insulin glulisine Subcutaneous-Emo-Cort Topical application